ClearSight Therapeutics
ClearSight Therapeutics is a Dallas-based biotech company founded in 2023 by eye care industry veterans. The company is dedicated to developing innovative, over-the-counter (OTC) solutions for common eye conditions such as dry eye and pink eye (acute infectious conjunctivitis). With a mission to disrupt the traditional OTC eye care industry, ClearSight leverages a proprietary platform that combines the dual-action potency of leading artificial tears and a powerful antimicrobial biopolymer. Their vision is to provide safe, effective, and accessible treatments that put patients first, while upholding ethical and responsible research and development practices.
What We Do
A next-generation OTC eye drop built on ClearSight's proprietary platform, combining artificial tears with a powerful antimicrobial biopolymer to soothe dry, irritated eyes and combat infection, rapidly reducing redness, swelling, and discomfort.
ClearSight Therapeutics develops over-the-counter treatments for common eye conditions, focusing on dry eye and pink eye, using a proprietary dual-action platform.
Application Area
Key People
Chief Executive Officer
Chief Scientific Officer
Lead Clinical Consultant
COO (Fractional)
CFO (Fractional)